Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Allergic Reactions02:06

Allergic Reactions

27.3K
Overview
27.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
Hypersensitivities01:30

Hypersensitivities

559
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
559
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

423
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
423
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

2.0K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Late syphilis presenting with extensive granulomatous cutaneous and pulmonary involvement.

IDCases·2026
Same author

Differential susceptibility of hair colour changes after barzolvolimab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Development and Validation of a Disease Severity Index for Patients With Cold Urticaria.

The journal of allergy and clinical immunology. In practice·2025
Same author

Validation of the Urticaria Activity Score for Cold Urticaria.

The journal of allergy and clinical immunology. In practice·2025
Same author

The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control.

The journal of allergy and clinical immunology. In practice·2024
Same author

Validation of the Cholinergic Urticaria Activity Score (CholUAS).

The journal of allergy and clinical immunology. In practice·2024

相关实验视频

Updated: Jun 14, 2025

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

2.7K

胆性疹的皮肤反应模式

Ilona Shurmelova1, Agata Baldyga2, Eva Grekowitz3

  • 1Department of Dermatology and Venerology, Kepler University Hospital, Linz, Austria.

Allergology international : official journal of the Japanese Society of Allergology
|September 5, 2024
PubMed
概括

在胆性尿疹 (CholU) 患者中发现了六种不同的皮肤反应模式,其患病率和与疾病严重程度和出汗障碍相关性各不相同. 需要进一步的研究来将这些模式与治疗反应联系起来.

关键词:
胆固醇性疹是一种疹.临床图片 临床图片皮肤反应 皮肤反应流汗 流汗 流汗 流汗威尔·威尔 (Wheel Wheal) 是一个叫做"小麦"的小麦.

更多相关视频

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

相关实验视频

Last Updated: Jun 14, 2025

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

2.7K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

科学领域:

  • 皮肤病学 皮肤病学
  • 免疫学 免疫学 免疫学
  • 过敏 过敏是一种过敏.

背景情况:

  • 胆性疹 (CholU) 呈现出各种不同的皮肤反应.
  • 这些模式的定义,患病率和临床意义尚未得到充分理解.

研究的目的:

  • 在CholU.U.中定义和描述不同的皮肤反应模式.
  • 调查这些模式的流行率和临床相关性.

主要方法:

  • 患有CholU的患者接受了人体工程学挑测试.
  • 分析了皮肤反应模式,基于小麦的特征和周围皮肤的反应.

主要成果:

  • 确定了六种不同的CholU皮肤反应类型,患病率从11%到83%不等.
  • 大多数患者 (94%) 呈现多种反应类型.
  • 减少出汗是常见的,在VI型反应 (四肢) 中最明显.
  • 类型V反应与严重的临床表现和生活质量差相关.

结论:

  • 皮肤反应是多样化的,经常同时发生.
  • 特定的皮肤症状与明显的临床特征和疾病严重程度有关.
  • 未来的研究应该探索治疗反应与已识别的皮肤模式的相关性.